New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo
Oncology April 24,2024
Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo
Oncology April 24,2024
Drug candidate granted FDA orphan drug status for pancreatic cancer

Drug candidate granted FDA orphan drug status for pancreatic cancer

by Roswell Park Comprehensive Cancer CenterCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.3c01589The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug
Breakthroughs April 23,2024
Drug candidate granted FDA orphan drug status for pancreatic cancer

Drug candidate granted FDA orphan drug status for pancreatic cancer

by Roswell Park Comprehensive Cancer CenterCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.3c01589The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug
Breakthroughs April 23,2024
Study questions benefit of new Alzheimer's drug

Study questions benefit of new Alzheimer's drug

by Lauren Baggett,University of GeorgiaCredit: CC0 Public DomainLast summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. Bu
Neurology April 23,2024
Study questions benefit of new Alzheimer's drug

Study questions benefit of new Alzheimer's drug

by Lauren Baggett,University of GeorgiaCredit: CC0 Public DomainLast summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. Bu
Neurology April 23,2024
Parents scrambling after asthma inhaler Flovent removed from market

Parents scrambling after asthma inhaler Flovent removed from market

by Dennis ThompsonA popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly pres
Immunology & Rheumatology April 23,2024
Parents scrambling after asthma inhaler Flovent removed from market

Parents scrambling after asthma inhaler Flovent removed from market

by Dennis ThompsonA popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly pres
Immunology & Rheumatology April 23,2024
Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc
Oncology April 23,2024
Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc
Oncology April 23,2024
How new drug approvals are reshaping treatment for eosinophilic esophagitis

How new drug approvals are reshaping treatment for eosinophilic esophagitis

by Morgan Duerden,University of North Carolina School of MedicineCredit: Pixabay/CC0 Public DomainEosinophilic esophagitis (EoE) is an allergic inflammatory disorder that affects the esophagus,
Gastroenterology April 23,2024
How new drug approvals are reshaping treatment for eosinophilic esophagitis

How new drug approvals are reshaping treatment for eosinophilic esophagitis

by Morgan Duerden,University of North Carolina School of MedicineCredit: Pixabay/CC0 Public DomainEosinophilic esophagitis (EoE) is an allergic inflammatory disorder that affects the esophagus,
Gastroenterology April 23,2024
Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis

Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis

by Elana GotkineFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published i
Immunology & Rheumatology April 23,2024
Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis

Oral interleukin-23-receptor antagonist peptide shows greater efficacy than placebo for plaque psoriasis

by Elana GotkineFor patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published i
Immunology & Rheumatology April 23,2024
Huge delays in dealing with complaints against UK drug companies revealed

Huge delays in dealing with complaints against UK drug companies revealed

by British Medical JournalCredit: Pixabay/CC0 Public DomainProcessing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripl
Oncology April 23,2024
Huge delays in dealing with complaints against UK drug companies revealed

Huge delays in dealing with complaints against UK drug companies revealed

by British Medical JournalCredit: Pixabay/CC0 Public DomainProcessing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripl
Oncology April 23,2024
Bacterial fragments from leaky gut help drive obesity, study shows

Bacterial fragments from leaky gut help drive obesity, study shows

by Nottingham Trent UniversityBody mass index (BMI) correlates with reduced brown adipose tissue genes. The expression of key brown fat genes Cell death-inducing DFFA-like effector A (CIDEA), ELO
Diabetes & Endocrinology April 23,2024
Bacterial fragments from leaky gut help drive obesity, study shows

Bacterial fragments from leaky gut help drive obesity, study shows

by Nottingham Trent UniversityBody mass index (BMI) correlates with reduced brown adipose tissue genes. The expression of key brown fat genes Cell death-inducing DFFA-like effector A (CIDEA), ELO
Diabetes & Endocrinology April 23,2024
Bloating common issue among Americans, study reports

Bloating common issue among Americans, study reports

by Cedars-Sinai Medical CenterGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.10.031Nearly 1 in 7 Americans experience bloating on a
Gastroenterology April 23,2024
Bloating common issue among Americans, study reports

Bloating common issue among Americans, study reports

by Cedars-Sinai Medical CenterGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.10.031Nearly 1 in 7 Americans experience bloating on a
Gastroenterology April 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com